Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott gains Indian nutrition brands

This article was originally published in The Tan Sheet

Executive Summary

With the acquisition of Mumbai-based Wockhardt Ltd. nutritionals firm and products including the Farex, Dexolac and Nusobee formula brands, Abbott takes the No. 2 spot in India's pediatric nutrition category. The company also gains Protinex, the adult protein supplement segment leader, Abbott said July 28. Abbott's $130 million purchase of Wockhardt and certain subsidiaries provides the Abbott Park, Ill.-based firm manufacturing and commercial infrastructure in India, said Executive VP of Global Nutrition Holger Liepmann. While Abbott has experienced robust nutritionals growth recently in China, Southeast Asia and Latin America, negative effects of currency exchange hurt global sales figures in its fiscal 2009 second quarter (1"The Tan Sheet" July 20, 2009)
Advertisement

Related Content

Sales & Earnings In Brief
Sales & Earnings In Brief
Sales & Earnings In Brief

Topics

Advertisement
UsernamePublicRestriction

Register

PS103173

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel